Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 41 points (0.2%) at 18,014 as of Friday, Feb. 13, 2015, 11:55 AM ET. The NYSE advances/declines ratio sits at 1,903 issues advancing vs. 1,059 declining with 158 unchanged.

The Health Care sector currently sits up 0.5% versus the S&P 500, which is up 0.2%. On the negative front, top decliners within the sector include Celgene ( CELG), down 1.2%, and UnitedHealth Group ( UNH), down 0.8%. Top gainers within the sector include GlaxoSmithKline ( GSK), up 4.0%, Sanofi ( SNY), up 1.8%, Shire ( SHPG), up 1.4%, Actavis ( ACT), up 1.2% and Novo Nordisk A/S ( NVO), up 0.9%.

TheStreet would like to highlight 3 stocks pushing the sector lower today:

3. DaVita HealthCare Partners ( DVA) is one of the companies pushing the Health Care sector lower today. As of noon trading, DaVita HealthCare Partners is down $4.23 (-5.5%) to $72.16 on heavy volume. Thus far, 2.9 million shares of DaVita HealthCare Partners exchanged hands as compared to its average daily volume of 938,000 shares. The stock has ranged in price between $71.89-$75.64 after having opened the day at $75.28 as compared to the previous trading day's close of $76.39.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

DaVita HealthCare Partners Inc. provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease. It operates kidney dialysis centers and provides related lab services primarily in outpatient dialysis centers and in contracted hospitals. DaVita HealthCare Partners has a market cap of $16.3 billion and is part of the health services industry. Shares are up 0.9% year-to-date as of the close of trading on Thursday. Currently there are 6 analysts that rate DaVita HealthCare Partners a buy, no analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates DaVita HealthCare Partners as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, compelling growth in net income, revenue growth and notable return on equity. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full DaVita HealthCare Partners Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

2. As of noon trading, Aetna ( AET) is down $0.90 (-0.9%) to $96.18 on light volume. Thus far, 404,116 shares of Aetna exchanged hands as compared to its average daily volume of 2.2 million shares. The stock has ranged in price between $95.89-$96.89 after having opened the day at $96.58 as compared to the previous trading day's close of $97.08.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Aetna Inc. operates as a diversified health care benefits company in the United States. The company operates in three segments: Health Care, Group Insurance, and Large Case Pensions. Aetna has a market cap of $33.9 billion and is part of the health services industry. Shares are up 9.3% year-to-date as of the close of trading on Thursday. Currently there are 11 analysts that rate Aetna a buy, no analysts rate it a sell, and 6 rate it a hold.

TheStreet Ratings rates Aetna as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance and revenue growth. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Aetna Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

1. As of noon trading, Teva Pharmaceutical Industries ( TEVA) is down $0.36 (-0.6%) to $56.99 on average volume. Thus far, 2.2 million shares of Teva Pharmaceutical Industries exchanged hands as compared to its average daily volume of 4.0 million shares. The stock has ranged in price between $56.92-$57.28 after having opened the day at $57.09 as compared to the previous trading day's close of $57.35.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Teva Pharmaceutical Industries Limited, together with its subsidiaries, develops, manufactures, sells, and distributes pharmaceutical products worldwide. The company offers generic pharmaceutical products; and basic chemicals, as well as specialized product families. Teva Pharmaceutical Industries has a market cap of $48.5 billion and is part of the drugs industry. Shares are down 0.3% year-to-date as of the close of trading on Thursday. Currently there are 12 analysts that rate Teva Pharmaceutical Industries a buy, no analysts rate it a sell, and 10 rate it a hold.

TheStreet Ratings rates Teva Pharmaceutical Industries as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, compelling growth in net income, reasonable valuation levels and good cash flow from operations. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full Teva Pharmaceutical Industries Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

null